SIRT1 and non-small cell lung carcinoma: SIRT1 promotes cisplatin resistance of NSCLC cells by elevating vascular endothelial growth factor A expression.426 SIRT1 is upregulated in cisplatin-resistant NSCLC tissues and cells compared to cisplatin-sensitive groups.291 SIRT1 silencing enhances the cisplatin sensitivity of H1299/cisplatin cells via suppressing autophagy.